Senior Vice President, Sales · TREACE MEDICAL CONCEPTS, INC. (TMCI)

Aaron Berutti

A named executive officer of TREACE MEDICAL CONCEPTS in every fiscal year CompBrief holds from FY2021 to FY2023. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2023

$3,262,358

Salary $365,233Stock awards $2,063,917

FY2022: $1,428,785

3rd of 5 named executive officers at Treace Medical Concepts by FY2023 total.

5 named officers on file for TREACE MEDICAL CONCEPTS, FY2023

Aaron Berutti’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 3 equity grants, each cited to its filing
  • TMCI’s disclosed peer group of 21 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how TREACE MEDICAL CONCEPTS’s whole pay program stands against its peers

  • TREACE MEDICAL CONCEPTS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on TMCI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 2, 2024 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Aaron Berutti’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Aaron Berutti compensation by year

TREACE MEDICAL CONCEPTS Summary Compensation Table · all 3 fiscal years held
In US dollars, as TREACE MEDICAL CONCEPTS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021FY2022FY2023
Salary$116,538$333,644$365,233
Bonus$10,000$0$0
Stock awards$0$228,843$2,063,917
Option awards$1,607,550$680,527$714,218
Non-equity incentive$55,000$173,000$104,000
Pension and deferred compensation$0$0$0
All other$142,085$12,771$14,990
Total$1,931,173$1,428,785$3,262,358

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: TREACE MEDICAL CONCEPTS, INC. DEF 14A filed April 2, 2024, accession 0000950170-24-040228, and prior-year filings. Open the filing on EDGAR.

How this page was built: the TREACE MEDICAL CONCEPTS, INC. filed document, accession 0000950170-24-040228. Every figure is read from that document and cited to the page and table it appears in. Filed April 2, 2024.

$1.9M
$1.4M
$3.3M
FY21
FY22
FY23
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
PSU42,900$546,975—
RSU29,800$379,950—
RSU8,962$114,266—
Option75,000—$29.26
Option67,500—$24.07
Option69,075—$19.15

Per the Outstanding Equity Awards at Fiscal Year-End table in TREACE MEDICAL CONCEPTS, INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

5 Form 4 lines since the FY2023 proxy (filed April 2, 2024)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-08-09Tax withholding—4,907$0.00205,092
2025-03-10Tax withholding—1,815$0.00209,999
2025-03-08Tax withholding—728$0.00211,814
2025-01-22Grant or award—75,000$0.00212,542
2025-01-10Tax withholding—4,821$0.00160,970

The 5 most recent of 5 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

TREACE MEDICAL CONCEPTS’s named executive officers, FY2023

as the company reported each
Named executive officerRoleFY2023 total
John TreaceChief Executive Officer, Director and Founder$8,422,635
Mark HairChief Financial Officer$4,686,509
Aaron Berutti · this pageSenior Vice President, Sales$3,262,358
Scot ElderChief Legal & Compliance Officer, Corporate Secretary$3,156,616
Sean ScanlanChief Innovation Officer$2,949,878

The full TREACE MEDICAL CONCEPTS compensation record

free company brief

This page is one person within TREACE MEDICAL CONCEPTS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the TREACE MEDICAL CONCEPTS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are TREACE MEDICAL CONCEPTS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Aaron Berutti's compensation dossier · One-time report. No refunds.